摘要
目的 探究冠心宁注射液关节腔注射辅助治疗股骨头坏死的效果。方法 选取2023.1-2023.12期间我院收治的股骨头坏死患者80例,按照数字随机法分为对照组和观察组,每组各40例患者,对照组使用氟比洛芬酯注射液进行治疗,观察组在对照组的基础上,加入冠心宁注射液辅助治疗,对比两组治疗后的髋关节功能和疼痛程度。结果 观察组的髋关节功能明显优于对照组,差异具有统计学意义(p<0.05);观察组的疼痛程度明显轻于对照组,差异具有统计学意义(p<0.05)。结论 冠心宁注射液关节腔注射辅助治疗股骨头坏死有显著效果,能够有效地改善患者的髋关节功能,减轻疼痛程度,值得临床实践应用。
关键词: 冠心宁注射液;辅助治疗;股骨头坏死;氟比洛芬酯注射液
Abstract
Objective A study on the adjuvant treatment of femoral head necrosis with joint cavity injection of Guanxinning injection. Methods Select 80 patients with femoral head necrosis admitted to our hospital from January 2023 to December 2023, and randomly divide them into a control group and an observation group according to the numerical randomization method, with 40 patients in each group. The control group is treated with flurbiprofen axetil injection, while the observation group is treated with Guanxinning injection as an adjuvant therapy on the basis of the control group. Compare the hip joint function and pain level of the two groups after treatment. Results The hip joint function of the observation group was significantly better than that of the control group, and the difference was statistically significant (p<0.05); The pain level in the observation group was significantly milder than that in the control group, and the difference was statistically significant (p<0.05). Conclusion The joint cavity injection of Guanxinning injection has a significant effect on the adjuvant treatment of femoral head necrosis, which can effectively improve hip joint function and alleviate pain in patients, and is worthy of clinical practice application.
Key words: Guanxinning Injection; Adjuvant therapy; Femoral head necrosis; Aspirin
参考文献 References
[1] 李扬,陈晓东. 股骨头坏死的保髋治疗[J]. 临床外科杂志,2023,31(4):304-307.
[2] 孙昭杰,张宁,李明阳,等. 激素性股骨头坏死的中西医治疗进展[J]. 中医药学报,2023,51(6):105-109.
[3] 成衍男,潘振宇. 激素性股骨头坏死发病机制的研究进展[J]. 临床外科杂志,2023,31(4):301-304.
[4] 景继禹,邓迎杰,方锐. 成人非创伤性股骨头坏死中医诊疗进展[J]. 中国疗养医学,2023,32(4):385-388.
[5] 张睿智,丁艳谱,李响明,等. 冠心宁注射液配伍稳定性研究[J]. 亚太传统医药,2020,16(4):63-66.
[6] 程振田,袁祥萍,武文斌,等. 冠心宁注射液安全药理学研究[J]. 药学研究,2020,39(9):514-516,524.
[7] 崔伊凡,梁军,郑晓芬,等. 冠心宁注射液稳定性影响因素研究[J]. 中草药,2020,51(14):3686-3692.
[8] 杨海燕,辛琰琰,周继春,等. 冠心宁注射液中细菌内毒素含量的微量动态显色法定量检测研究[J]. 中医药导报,2020,26(12):40-43,46.